Non Invasive Blood Test To Diagnose Acute Rejection After Kidney Transplantation (DART)
Circulating Donor-Derived Cell-free DNA in Blood for Diagnosing Acute Rejection in Kidney Transplant Recipients
Sponsor: CareDx
Listed as NCT02424227, this observational or N/A phase trial focuses on Kidney Transplant Recipients and remains ongoing. Sponsored by CareDx, it has been updated 14 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
▶ Show 9 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jan 2019 — Nov 2020 [monthly]
Active Not Recruiting
-
Oct 2018 — Jan 2019 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
Jul 2018 — Oct 2018 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
May 2018 — Jun 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — May 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CareDx
For direct contact, visit the study record on ClinicalTrials.gov .